Associated Press
Stocks Plunge on Inflation Worries, IBM
Friday April 15, 3:24 pm ET
By Michael J. Martinez, AP Business Writer
Stocks Plunge on Inflation Worries, Disappointing IBM Earnings; Dow Falls More Than 100 Points
NEW YORK (AP) -- Wall Street extended its selloff Friday after industrial production figures pointed to a slowing economy and higher prices on imports fed investors' inflation worries. Disappointing earnings from IBM Corp. exacerbated the selling, with the Dow Jones industrials down more than 100 points for the third day in row.
ADVERTISEMENT
In midafternoon trading, the Dow fell 113.50, or 1.1 percent, to 10,165.25, after falling 125 points on Thursday and 104 points on Wednesday. Broader stock indicators also lost considerable ground. The Standard & Poor's 500 index was down 10.41, or 0.9 percent, at 1,151.64, and the Nasdaq composite index dropped 25.79, or 1.3 percent, to 1,920.92.
An already uneasy market was disappointed as Federal Reserve reported drops in manufacturing and other industrial production. A Labor Department report also showed higher oil costs driving up import prices and worsening Wall Street's chronic inflation worries.
The negative impact of the economic data on stocks was bolstered by lower-than-expected profits from IBM. Strong earnings from General Electric Co. and Citigroup Inc. were overlooked, but analysts said earnings would nonetheless be a key factor in overcoming the recent selloff.
"Earnings are really the only hope for this market," said Brian Pears, head equity trader at Victory Capital Management in Cleveland. "If, on the whole, earnings can go up, then we might be able to overcome oil and inflation and all the other things. If they go down, we'll sell off further."
All three indexes fell to five-month lows on Thursday, prompted by disappointing earnings forecasts from Apple Computer Inc. and worries about the prospects for steady economic growth. Should the Dow close 100 points lower, it would be the first time since January 2003 that the index posted three straight 100-point losses.
Bonds continued to rally, with the yield on the 10-year Treasury note falling to 4.27 percent from 4.34 percent late Thursday. The dollar was mixed against other major currencies, while gold prices moved higher.
Crude oil prices were lower after Thursday's rally, with a barrel of light crude quoted at $50.55, down 58 cents, on the New York Mercantile Exchange.
The sharp rise in oil prices so far this year is to blame for the jump in import prices, the Labor Department said. Import costs rose 1.8 percent in March, but even without oil, prices rose 0.3 percent, which is still more than the 0.2 percent rise economists had expected.
"There's a lot of evidence that when we have oil averaging $53 or $54 per barrel, that's inflationary, and we got a whiff of that today in the import prices," said Peter Cardillo, chief strategist and senior vice president with S.W. Bach & Co. "It doesn't help that we're starting to see the economy enter a slowing mode heading into the second quarter here."
Investors looking at the Fed's industrial output report also questioned whether higher energy and materials costs were affecting manufacturing growth as well. Overall industrial production rose 0.3 percent in March, up from 0.2 percent in February, but the increase came only from utility production due to a colder-than-average month, and manufacturing and other industrial sectors showed losses for the first time in six months.
IBM said an inability to close deals before the end of the quarter, combined with higher pension costs, dragged on its earnings. The technology company, which missed Wall Street forecasts by 6 cents per share, hinted at a major restructuring this year. IBM tumbled $6.51, or 7.8 percent to $77.13.
General Electric rose 76 cents to $36.26 after the industrial and media conglomerate reported a 25 percent jump in first-quarter profits, with nine of the company's 11 disparate divisions reporting double-digit growth. The company's forecasts for the second quarter and full year were in line with Wall Street's estimates.
Citigroup beat Wall Street's expectations for its quarterly profits by 2 cents per share, with profits rising a modest 3 percent year-over-year. The financial company also said its board had authorized the repurchase of an additional $15 billion in stock. Citigroup added 79 cents to $46.19.
The lagging pharmaceutical sector saw new life after Genentech Inc. reported strong results from trials of its Avastin drug in breast cancer patients, and Ely Lilly & Co. received a favorable patent ruling on its best-selling anti-psychotic drug Zyprexa. Genentech surged $11.26, or 19.2 percent, to $69.89, while Lilly climbed $3.75 to $58.91.
Declining issues outnumbered advancers by more than 3 to 1 on the New York Stock Exchange, where volume came to 1.63 billion shares, compared with 1.45 billion at the same point on Thursday.
The Russell 2000 index of smaller companies was down 7.40, or 1.2 percent, at 584.54.
Thursday's losses in U.S. markets had a ripple effect overseas, as the Nikkei stock average fell 1.66 percent. In Europe, Britain's FTSE 100 closed down 1.09 percent, France's CAC-40 lost 1.92 percent for the session, and Germany's DAX index tumbled 2.04 percent in late trading.
New York Stock Exchange:
http://www